Australia markets open in 2 hours 40 minutes

Cryosite Limited (CTE.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.6700-0.0050 (-0.74%)
At close: 10:02AM AEDT

Cryosite Limited

13a Ferndell Street
South Granville, NSW 2142
61 2 8865 2000

IndustryDiagnostics & Research
Full-time employees22

Key executives

NameTitlePayExercisedYear born
Mr. John HoggChief Exec. Officer250kN/AN/A
Ms. Jane HaoChief Financial Officer173.25kN/AN/A
Ms. Kim Bradley-Ware B.Com., CPA, L.L.B.Company Sec.N/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport, and biological storage solutions to the clinical trials, and research and pharmaceutical industry. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia.

Corporate governance

Cryosite Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.